$2.97
-$0.02
(-0.67%)
Quote as of 4:00 PM EST on 02/10/12
Albany Molecular Research, Inc...
NASDAQ:AMRI
Extended Hours:
$2.97
$0.00
(0.00%)
Quote as of 5:15 PM EST on 02/10/12 (NASDAQ)
|
$2.97
-$0.02
(-0.67%)
|
|
| Today's Open | $2.98 |
|---|---|
| Previous Close | $2.99 |
| Daily Range | $2.90 - $3.04 |
| 52-Week Range | $2.08 - $5.55 |
| Market Cap | $91.00M |
| P/E Ratio | -7.12 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 54,832 |
| Average Daily Volume | 67,762 |
| Current FY EPS | $0.07 |
AMRI Information
| Description |
|---|
| The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market. |
| Sector |
| Healthcare |
| Industry |
| Life Sciences Tools and Services |
News & Commentary
Registration Effectiveness Orders Issued By The SEC
Our Investor Outlook: Cautious and Protected
UPDATE: Dr Reddy's Gets US Court OK To Sell Generic Allegra D-24
Sifting Through the Rubble of 2010: 9 Beaten Up, Deep-Value Small Caps
Value Opportunities Created by Mutual Fund Selling
Analyst Calls: AMAT, AMRI, BP, BUCY, DB, FDO, GS, ISIL, THO ...
UPDATE 1-Albany Molecular seeks injunction against Dr Reddy's
